According to the latest data from the Hong Kong Stock Exchange, on January 6, JPMorgan increased its holding in Hengrui Pharma (01276) by approximately 1.13 million shares. The transaction was executed at a price of HK$74.6126 per share, resulting in a total investment of around HK$84.15 million.
Following this acquisition, JPMorgan's total shareholding in the company has risen to approximately 19.194 million shares. This represents a latest持股比例 of 7.43%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments